Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Vitamin A Supplementation in Allogeneic Stem Cell Transplantation
NCT06450925Phase 2Recruiting
- Sponsor
- Cincinnati Children's Hospital Medical Center
- Start
- Mar 2025
- Primary completion
- Aug 2027
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in graft-versus-host disease (GVHD) comparing Vitamin A with Placebo (2 arms). Primary endpoint: Incidence of moderate-severe chronic graft versus host disease (GVHD) at 1 year. Started Mar 2025; status: recruiting.
02
Drugs
vitamin a
03
Conditions
graft-versus-host disease (GVHD)
Beyond the preview
Go deeper on NCT06450925.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06450925.